Thrombosis News and Research

Latest Thrombosis News and Research

Sticking to clinical guidelines decreases deep vein thrombosis in elderly

A multifaceted intervention designed to increase adherence with clinical guidelines for preventing deep-vein blood clots may decrease the rate of such blood clots among elderly patients, according to a report in the October 23 issue of Archives of Internal Medicine.

23 Oct 2006

Idaho woman files lawsuit over Ortho Evra patch

A woman in Idaho who said she developed a blood clot disorder after using the birth control patch Ortho Evra -- made by Ortho-McNeil, a subsidiary of Johnson & Johnson -- has filed a lawsuit in federal court against the companies, the AP/Houston Chronicle reports.

19 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

New class of super NSAIDs

Building on previous work, researchers at the University of Pennsylvania School of Medicine have found that deleting an inflammation enzyme in a mouse model of heart disease slowed the development of atherosclerosis.

12 Sep 2006

Aspirin resistance: Fact or fable?

Coronary heart disease is the single leading cause of death in the Western world. Aspirin is a fundamental part of the prevention and treatment of coronary heart disease and is used by millions of patients worldwide.

5 Sep 2006

Preventing bleeding is key to the treatment of acute coronary syndromes

On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.

5 Sep 2006

Drug-coated stents increase the risk of blood clots

Heart experts attending the World Congress of Cardiology have expressed their concerns over the long-term safety record of drug-coated stents.

5 Sep 2006

Renal transplantation in children with posterior uUrethral valves

The first description of posterior urethral valves (PUV) was made more than 80 years ago by Hugh Hampton Young and represents a spectrum of severity, ranging from disease incompatible with postnatal life to minimal symptoms that may not manifest until later in life.

17 Aug 2006

Pycnogenol effective in reducing leg swelling, walking pain

Significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol.

12 Jul 2006

New class of experimental drug that targets master regulator gene called c-Jun

University of New South Wales (UNSW) researchers have announced they are developing a new class of experimental drug that has the potential to treat a diverse range of health problems, from inflammation and cancer through to eye and heart disease.

3 Jul 2006

Chlorhexidine decreases risk of acquiring hospital-related ventilator-associated pneumonia

Researchers found that administering the topical antiseptic chlorhexidine to critically ill patients on mechanical ventilation greatly decreased their daily risk of acquiring deadly hospital-related ventilator-associated pneumonia.

18 Jun 2006

Study finds ways to improve detection of blood clots in the lung

Largest study ever conducted to assess the role of contrast-enhanced multidetector computed tomographic (CT) angiography for diagnosing pulmonary embolism.

5 Jun 2006

COX-1 and COX-2 enzymes may be blocked by pain medications

COX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and Vioxx in a more complex manner than was previously understood, a Queen's University study has found.

29 May 2006

No link between low air-pressure on long-haul flights and DVT

Researchers simulating conditions of reduced cabin pressure and reduced oxygen levels, such as may be encountered during an 8-hour aeroplane flight, found no increase in the activation of the blood clotting system among healthy individuals

17 May 2006

DVT and long haul flights - air pressure and oxygen levels not the culprits

According to new research from the UK the reduced air pressure and oxygen levels experienced by travellers on long flights are not responsible for the formation of deadly blood clots often referred to as "economy class syndrome".

17 May 2006

Discovery of two gene variants associated with increased risk for early heart attack

Scientists at University of California - San Francisco (UCSF), Celera Genomics and The Cleveland Clinic have discovered two gene variants associated with a significantly increased risk for early heart attack, or myocardial infarction (MI).

12 May 2006

Long-term estrogen therapy may be related to a higher risk of breast cancer

Previous studies have linked the use of hormone therapy to breast cancer among postmenopausal women, but have primarily focused on the hormone combination of estrogen plus progestin, according to background information in the article.

9 May 2006

Alternative anti-inflammatory drugs promise less cardiovascular problems

New type of anti-inflammatory drugs may reduce COX-2 cardiovascular problems, says Queen's researcher

25 Apr 2006

Made to measure medical stockings

The University of Manchester's William Lee Innovation Centre (WLIC) has unveiled a new medical system which knits made to measure compression stockings.

From The University of Manchester 19 Apr 2006